van der Graaf W - Search Results

1

Imatinib mesylate (STI-571 Glivec, Gleevec) is an active agent for gastrointestinal stromal tumours, but does not yield responses in other soft-tissue sarcomas that are unselected for a molecular target. Results from an EORTC Soft Tissue and Bone Sarcoma Group phase II study.

Verweij J, van Oosterom A, Blay JY, Judson I, Rodenhuis S, van der Graaf W, Radford J, Le Cesne A, Hogendoorn PC, di Paola ED, Brown M, Nielsen OS. Verweij J, et al. Among authors: van oosterom a, van der graaf w. Eur J Cancer. 2003 Sep;39(14):2006-11. Eur J Cancer. 2003. PMID: 12957454 Clinical Trial.

2

Phase II study of intraperitoneal cisplatin plus systemic etoposide as second-line treatment in patients with small volume residual ovarian cancer.

de Jong RS, Willemse PH, Boonstra H, de Vries EG, van der Graaf WT, Sleijfer DT, van der Zee AG, Mulder NH. de Jong RS, et al. Among authors: van der graaf wt, van der zee ag. Eur J Cancer. 1995;31A(5):709-13. doi: 10.1016/0959-8049(94)00516-8. Eur J Cancer. 1995. PMID: 7640042 Clinical Trial.

3

5-Fluorouracil/leucovorin/interferon alpha-2a in patients with advanced colorectal cancer. Effects of maintenance therapy on remission duration.

Buter J, Sinnige HA, Sleijfer DT, de Vries EG, Willemse PH, van der Graaf WT, Verschueren RC, Mulder NH. Buter J, et al. Among authors: van der graaf wt. Cancer. 1995 Mar 1;75(5):1072-6. doi: 10.1002/1097-0142(19950301)75:5<1072::aid-cncr2820750504>3.0.co;2-s. Cancer. 1995. PMID: 7850703 Clinical Trial.

4

Epidemiological aspects of soft tissue sarcomas (STS)--consequences for the design of clinical STS trials.

Nijhuis PH, Schaapveld M, Otter R, Molenaar WM, van der Graaf WT, Hoekstra HJ. Nijhuis PH, et al. Among authors: van der graaf wt. Eur J Cancer. 1999 Nov;35(12):1705-10. doi: 10.1016/s0959-8049(99)00152-5. Eur J Cancer. 1999. PMID: 10674017

5

Improved long term survival of patients with metastatic nonseminomatous testicular germ cell carcinoma in relation to prognostic classification systems during the cisplatin era.

Sonneveld DJ, Hoekstra HJ, van der Graaf WT, Sluiter WJ, Mulder NH, Willemse PH, Koops HS, Sleijfer DT. Sonneveld DJ, et al. Among authors: van der graaf wt. Cancer. 2001 Apr 1;91(7):1304-15. Cancer. 2001. PMID: 11283931

6

Expression of P-glycoprotein, multidrug resistance-associated protein 1, and lung resistance-related protein in human soft tissue sarcomas before and after hyperthermic isolated limb perfusion with tumor necrosis factor-alpha and melphalan.

Komdeur R, Plaat BE, Hoekstra HJ, Molenaar WM, Hollema H, van den Berg E, Mastik MF, van der Graaf WT. Komdeur R, et al. Among authors: van der graaf wt, van den berg e. Cancer. 2001 May 15;91(10):1940-8. Cancer. 2001. PMID: 11346877

7

PNU-145156E, a novel angiogenesis inhibitor, in patients with solid tumors: a phase I and pharmacokinetic study.

Groen HJ, de Vries EG, Wynendaele W, van der Graaf WT, Fokkema E, Lechuga MJ, Poggesi I, Dirix LY, van Oosterom AT. Groen HJ, et al. Among authors: van der graaf wt, van oosterom at. Clin Cancer Res. 2001 Dec;7(12):3928-33. Clin Cancer Res. 2001. PMID: 11751484 Clinical Trial.

8

Metastasis in soft tissue sarcomas: prognostic criteria and treatment perspectives.

Komdeur R, Hoekstra HJ, van den Berg E, Molenaar WM, Pras E, de Vries EG, van der Graaf WT. Komdeur R, et al. Cancer Metastasis Rev. 2002;21(2):167-83. doi: 10.1023/a:1020893200768. Cancer Metastasis Rev. 2002. PMID: 12465756 Review.

9

Expression of multidrug resistance proteins, P-gp, MRP1 and LRP, in soft tissue sarcomas analysed according to their histological type and grade.

Komdeur R, Plaat BE, van der Graaf WT, Hoekstra HJ, Hollema H, van den Berg E, Zwart N, Scheper RJ, Molenaar WM. Komdeur R, et al. Among authors: van der graaf wt, van den berg e. Eur J Cancer. 2003 May;39(7):909-16. doi: 10.1016/s0959-8049(03)00029-7. Eur J Cancer. 2003. PMID: 12706359

10

Clinicopathologic assessment of postradiation sarcomas: KIT as a potential treatment target.

Komdeur R, Hoekstra HJ, Molenaar WM, Van Den Berg E, Zwart N, Pras E, Plaza-Menacho I, Hofstra RM, Van Der Graaf WT. Komdeur R, et al. Among authors: van der graaf wt, van den berg e. Clin Cancer Res. 2003 Aug 1;9(8):2926-32. Clin Cancer Res. 2003. PMID: 12912938

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

634 results

Search Page